Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control

Abroad (travel likely)RecruitingPHASE4

Conditions

T2DM (Type 2 Diabetes Mellitus)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Tianjin Medical University General Hospital, Tianjin, Tianjin Municipality, China
Contact: Study coordinator (Ming Liu) · mingliu@tmu.edu.cn · +86 183 2201 7516

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin

T2DM · Diabete Type 2 · DM

Abroad (travel likely)RecruitingPHASE3

Seoul, South Korea

The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy

Type 2 Diabetes · Diabetes With Diabetic Autonomic Neuropathy (Diagnosis)

Abroad (travel likely)RecruitingPHASE4

Nanjing, China

Optimization and Evaluation of the Diagnosis and Treatment System for Diabetic Retinopathy in Type 2 Diabetes Mellitus

Diabetes · Diabetic Retinopathy · Type 2 Diabetes Mellitus (T2DM)

Abroad (travel likely)Recruiting

Lanzhou, China · Shanghai, China

Ultrasound Effects on Glycemic Control in T2DM

Type 2 Diabetes

Abroad (travel likely)Recruiting

New Haven, United States